Precision Medicine News and Research

RSS

Cleveland Clinic-led study identifies features associated with pathogenic and benign variants

An international team of researchers led by Cleveland Clinic's Lerner Research Institute has performed for the first time a wide-scale characterization of missense variants from 1,330 disease-associated genes.

27 Oct 2020

Researchers use viral signatures to reveal transmission patterns of SARS-CoV-2

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

Biodynamic imaging illuminates ovarian cancer treatments

Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments. Even worse - many of those same patients experience toxic and sometimes deadly side effects.

22 Oct 2020

Life science sector is thriving in Northern Ireland

The growing importance of Northern Ireland’s pharmaceutical and life sciences industries is revealed today [Tuesday 20 October 2020] in a new report tracking the significant contribution the sector makes to the NI economy.

21 Oct 2020

UC study shows how tobacco use impacts patients with kidney cancer

Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

20 Oct 2020

NMR Metabolomics as Novel Screening Tool for New-borns (For Research Only)

In this interview, Oscar Millet, group leader of the Precision Medicine and Metabolism group of the CIC bioGUNE, talked to News Medical about his research into the use of nuclear magnetic resonance spectroscopy (NMR) metabolomic analysis as a clinical screening tool. His team has used NMR to screen urine samples form new-borns for congenital metabolic disorders.

From Bruker BioSpin Group 20 Oct 2020

Researchers map the first draft sequence of human proteome

Twenty years after the release of the human genome, the genetic "blueprint" of human life, an international research team, including the University of British Columbia's Chris Overall, has now mapped the first draft sequence of the human proteome.

20 Oct 2020

Cell nucleus may play role in enabling cells to evade crowded environments

Like people, cells in the human body protect their personal space. They seem to know how much space they need, and if it gets too tight, most cells prefer to break free.

19 Oct 2020

Ziath to participate in two key virtual biobanking symposia

Ziath announce their participation in two key virtual symposia for scientists involved in biobanking - the ISBER Virtual Symposium 2020 and the Europe Biobank Week 2020.

From Ziath Ltd 16 Oct 2020

New saliva tests can enable early detection and diagnosis of COVID-19, head & neck cancer

Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced today a broad strategic collaboration involving research, development and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

15 Oct 2020

Blood profile could help identify COVID-19 patients at greatest risk of deterioration

Southampton researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems' responses.

14 Oct 2020

First confirmed US case of SARS-CoV-2 reinfection

Of the cases of reinfections worldwide, a particular case has been reported by scientists at the Nevada Institute of Personalized Medicine, University of Nevada. A 25-year-old man from Washoe County in the United States, the hardest-hit country globally, has more than 7.85 million cases.

14 Oct 2020

EuCanImage to build scalable cancer imaging platform for next-generation artificial intelligence in oncology

EuCanImage has been launched. This project from the Horizon 2020 program is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science.

13 Oct 2020

NIH provides $9.3 million grant to create new Center for Precision Animal Modeling at UAB

A new Center for Precision Animal Modeling, or C-PAM, has been created at the University of Alabama at Birmingham, supported by a five-year, $9.3 million grant from the National Institutes of Health's Office of Research Infrastructure Programs.

9 Oct 2020

Researchers develop hand-held device to measure cancer biomarker

Researchers at McMaster and Brock universities have created the prototype for a hand-held device to measure a biomarker for cancer, paving the way for home-based cancer monitoring and to improve access to diagnostic testing.

9 Oct 2020

New computer program detects neurodegeneration biomarkers through magnetic resonance imaging

Magnetic resonance imaging is the most sensitive and reliable technique for diagnosing and monitoring neurodegenerative diseases.

8 Oct 2020

Study identifies the exact neurons that are most affected by epilepsy

Epilepsy is one of the most common neurological diseases. It is caused by a malfunction in brain cells and is usually treated with medicines that control or counteract the seizures.

7 Oct 2020

Using GWAS and trans-ancestry comparison to accurately predict risk for coronary artery disease

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

6 Oct 2020

Multi-ancestry comparison can accurately predict risk factors for coronary artery disease

An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis—or GWAS—and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.